nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—NR3C2—Progesterone—uterine cancer	0.523	0.757	CbGbCtD
Nimodipine—CYP3A5—Progesterone—uterine cancer	0.0617	0.0893	CbGbCtD
Nimodipine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0363	0.0526	CbGbCtD
Nimodipine—CYP3A5—Etoposide—uterine cancer	0.0276	0.04	CbGbCtD
Nimodipine—CYP3A4—Progesterone—uterine cancer	0.0241	0.0348	CbGbCtD
Nimodipine—CYP3A4—Etoposide—uterine cancer	0.0108	0.0156	CbGbCtD
Nimodipine—CYP3A4—Doxorubicin—uterine cancer	0.00734	0.0106	CbGbCtD
Nimodipine—CACNB3—myometrium—uterine cancer	0.00433	0.0466	CbGeAlD
Nimodipine—Phlebitis—Carboplatin—uterine cancer	0.00359	0.0275	CcSEcCtD
Nimodipine—CACNB3—uterine cervix—uterine cancer	0.00337	0.0363	CbGeAlD
Nimodipine—Deep vein thrombosis—Medroxyprogesterone Acetate—uterine cancer	0.00334	0.0255	CcSEcCtD
Nimodipine—CACNB3—decidua—uterine cancer	0.00321	0.0346	CbGeAlD
Nimodipine—AHR—myometrium—uterine cancer	0.00321	0.0345	CbGeAlD
Nimodipine—CACNB3—endometrium—uterine cancer	0.00305	0.0328	CbGeAlD
Nimodipine—CACNB4—vagina—uterine cancer	0.00298	0.0321	CbGeAlD
Nimodipine—CACNB3—mammalian vulva—uterine cancer	0.00295	0.0317	CbGeAlD
Nimodipine—CACNB3—uterus—uterine cancer	0.00281	0.0302	CbGeAlD
Nimodipine—Acne—Progesterone—uterine cancer	0.00266	0.0203	CcSEcCtD
Nimodipine—CACNB3—female reproductive system—uterine cancer	0.00253	0.0272	CbGeAlD
Nimodipine—AHR—uterine cervix—uterine cancer	0.0025	0.0269	CbGeAlD
Nimodipine—AHR—smooth muscle tissue—uterine cancer	0.00243	0.0261	CbGeAlD
Nimodipine—Acne—Medroxyprogesterone Acetate—uterine cancer	0.00241	0.0184	CcSEcCtD
Nimodipine—CACNB1—female gonad—uterine cancer	0.0024	0.0258	CbGeAlD
Nimodipine—AHR—decidua—uterine cancer	0.00238	0.0256	CbGeAlD
Nimodipine—CACNA1C—myometrium—uterine cancer	0.00235	0.0253	CbGeAlD
Nimodipine—CACNB3—female gonad—uterine cancer	0.0023	0.0247	CbGeAlD
Nimodipine—CACNB3—vagina—uterine cancer	0.00228	0.0246	CbGeAlD
Nimodipine—AHR—endometrium—uterine cancer	0.00226	0.0243	CbGeAlD
Nimodipine—AHR—mammalian vulva—uterine cancer	0.00218	0.0235	CbGeAlD
Nimodipine—NR3C2—myometrium—uterine cancer	0.00214	0.023	CbGeAlD
Nimodipine—Fluid retention—Progesterone—uterine cancer	0.00213	0.0163	CcSEcCtD
Nimodipine—AHR—uterus—uterine cancer	0.00208	0.0224	CbGeAlD
Nimodipine—Phosphatase alkaline increased—Medroxyprogesterone Acetate—uterine cancer	0.00203	0.0155	CcSEcCtD
Nimodipine—Lightheadedness—Progesterone—uterine cancer	0.002	0.0153	CcSEcCtD
Nimodipine—CACNA1D—uterine cervix—uterine cancer	0.00198	0.0213	CbGeAlD
Nimodipine—Fluid retention—Medroxyprogesterone Acetate—uterine cancer	0.00193	0.0147	CcSEcCtD
Nimodipine—AHR—female reproductive system—uterine cancer	0.00187	0.0201	CbGeAlD
Nimodipine—CACNA1C—smooth muscle tissue—uterine cancer	0.00178	0.0191	CbGeAlD
Nimodipine—CACNA1C—decidua—uterine cancer	0.00174	0.0187	CbGeAlD
Nimodipine—AHR—female gonad—uterine cancer	0.0017	0.0183	CbGeAlD
Nimodipine—Blood alkaline phosphatase increased—Medroxyprogesterone Acetate—uterine cancer	0.00169	0.0129	CcSEcCtD
Nimodipine—AHR—vagina—uterine cancer	0.00169	0.0182	CbGeAlD
Nimodipine—NR3C2—uterine cervix—uterine cancer	0.00166	0.0179	CbGeAlD
Nimodipine—Cardiac failure congestive—Medroxyprogesterone Acetate—uterine cancer	0.00162	0.0124	CcSEcCtD
Nimodipine—NR3C2—smooth muscle tissue—uterine cancer	0.00162	0.0174	CbGeAlD
Nimodipine—NR3C2—renal system—uterine cancer	0.00156	0.0167	CbGeAlD
Nimodipine—CACNB1—lymph node—uterine cancer	0.00154	0.0166	CbGeAlD
Nimodipine—CACNB2—vagina—uterine cancer	0.00153	0.0165	CbGeAlD
Nimodipine—NR3C2—endometrium—uterine cancer	0.0015	0.0162	CbGeAlD
Nimodipine—Liver function test abnormal—Progesterone—uterine cancer	0.0015	0.0115	CcSEcCtD
Nimodipine—CACNB3—lymph node—uterine cancer	0.00148	0.0159	CbGeAlD
Nimodipine—Cramp muscle—Progesterone—uterine cancer	0.00146	0.0112	CcSEcCtD
Nimodipine—NR3C2—mammalian vulva—uterine cancer	0.00146	0.0157	CbGeAlD
Nimodipine—Alanine aminotransferase increased—Progesterone—uterine cancer	0.00143	0.011	CcSEcCtD
Nimodipine—NR3C2—uterus—uterine cancer	0.00139	0.0149	CbGeAlD
Nimodipine—Sweating increased—Progesterone—uterine cancer	0.00137	0.0105	CcSEcCtD
Nimodipine—CACNA1C—female reproductive system—uterine cancer	0.00137	0.0147	CbGeAlD
Nimodipine—Phlebitis—Dactinomycin—uterine cancer	0.00133	0.0102	CcSEcCtD
Nimodipine—Cramp muscle—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.0101	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.00993	CcSEcCtD
Nimodipine—Lactic dehydrogenase activity increased—Epirubicin—uterine cancer	0.00126	0.00959	CcSEcCtD
Nimodipine—Depression—Progesterone—uterine cancer	0.00125	0.00955	CcSEcCtD
Nimodipine—NR3C2—female reproductive system—uterine cancer	0.00125	0.0134	CbGeAlD
Nimodipine—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00948	CcSEcCtD
Nimodipine—CACNA1C—vagina—uterine cancer	0.00124	0.0133	CbGeAlD
Nimodipine—Jaundice—Progesterone—uterine cancer	0.00122	0.00933	CcSEcCtD
Nimodipine—Hepatobiliary disease—Progesterone—uterine cancer	0.00119	0.00906	CcSEcCtD
Nimodipine—Lactic dehydrogenase activity increased—Doxorubicin—uterine cancer	0.00116	0.00888	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Etoposide—uterine cancer	0.00115	0.00876	CcSEcCtD
Nimodipine—NR3C2—female gonad—uterine cancer	0.00113	0.0122	CbGeAlD
Nimodipine—Depression—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.00865	CcSEcCtD
Nimodipine—NR3C2—vagina—uterine cancer	0.00113	0.0121	CbGeAlD
Nimodipine—Hepatitis—Progesterone—uterine cancer	0.00113	0.0086	CcSEcCtD
Nimodipine—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00846	CcSEcCtD
Nimodipine—Blood lactate dehydrogenase increased—Epirubicin—uterine cancer	0.00111	0.00845	CcSEcCtD
Nimodipine—AHR—lymph node—uterine cancer	0.00109	0.0118	CbGeAlD
Nimodipine—Hepatobiliary disease—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00821	CcSEcCtD
Nimodipine—Liver function test abnormal—Dactinomycin—uterine cancer	0.00106	0.00811	CcSEcCtD
Nimodipine—Cardiac disorder—Progesterone—uterine cancer	0.00104	0.00798	CcSEcCtD
Nimodipine—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00793	CcSEcCtD
Nimodipine—Blood lactate dehydrogenase increased—Doxorubicin—uterine cancer	0.00102	0.00782	CcSEcCtD
Nimodipine—Angiopathy—Progesterone—uterine cancer	0.00102	0.0078	CcSEcCtD
Nimodipine—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00779	CcSEcCtD
Nimodipine—Immune system disorder—Progesterone—uterine cancer	0.00102	0.00777	CcSEcCtD
Nimodipine—CACNB2—lymph node—uterine cancer	0.000993	0.0107	CbGeAlD
Nimodipine—Phlebitis—Etoposide—uterine cancer	0.000966	0.00738	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Etoposide—uterine cancer	0.000956	0.00731	CcSEcCtD
Nimodipine—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.000946	0.00723	CcSEcCtD
Nimodipine—Muscle spasms—Progesterone—uterine cancer	0.000942	0.0072	CcSEcCtD
Nimodipine—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.000925	0.00707	CcSEcCtD
Nimodipine—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000921	0.00704	CcSEcCtD
Nimodipine—Cardiac failure congestive—Etoposide—uterine cancer	0.000917	0.00701	CcSEcCtD
Nimodipine—Ileus—Epirubicin—uterine cancer	0.000908	0.00694	CcSEcCtD
Nimodipine—Anaemia—Progesterone—uterine cancer	0.000905	0.00692	CcSEcCtD
Nimodipine—CYP3A5—uterine cervix—uterine cancer	0.000899	0.00968	CbGeAlD
Nimodipine—CACNA1D—lymph node—uterine cancer	0.000868	0.00934	CbGeAlD
Nimodipine—Palpitations—Progesterone—uterine cancer	0.000865	0.00661	CcSEcCtD
Nimodipine—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.000853	0.00652	CcSEcCtD
Nimodipine—Hypertension—Progesterone—uterine cancer	0.000846	0.00646	CcSEcCtD
Nimodipine—CYP3A5—renal system—uterine cancer	0.000841	0.00905	CbGeAlD
Nimodipine—Ileus—Doxorubicin—uterine cancer	0.00084	0.00642	CcSEcCtD
Nimodipine—Myalgia—Progesterone—uterine cancer	0.000834	0.00637	CcSEcCtD
Nimodipine—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00082	0.00627	CcSEcCtD
Nimodipine—CACNA1C—lymph node—uterine cancer	0.000801	0.00862	CbGeAlD
Nimodipine—Oedema—Progesterone—uterine cancer	0.000799	0.00611	CcSEcCtD
Nimodipine—Hepatitis—Dactinomycin—uterine cancer	0.000795	0.00608	CcSEcCtD
Nimodipine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.000784	0.00599	CcSEcCtD
Nimodipine—Nervous system disorder—Progesterone—uterine cancer	0.000784	0.00599	CcSEcCtD
Nimodipine—Tachycardia—Progesterone—uterine cancer	0.00078	0.00596	CcSEcCtD
Nimodipine—Hyperhidrosis—Progesterone—uterine cancer	0.000773	0.0059	CcSEcCtD
Nimodipine—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000756	0.00577	CcSEcCtD
Nimodipine—Cramp muscle—Etoposide—uterine cancer	0.000749	0.00572	CcSEcCtD
Nimodipine—Hypotension—Progesterone—uterine cancer	0.000747	0.00571	CcSEcCtD
Nimodipine—Flushing—Dactinomycin—uterine cancer	0.000738	0.00564	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Etoposide—uterine cancer	0.000734	0.00561	CcSEcCtD
Nimodipine—NR3C2—lymph node—uterine cancer	0.000729	0.00785	CbGeAlD
Nimodipine—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000728	0.00556	CcSEcCtD
Nimodipine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000724	0.00553	CcSEcCtD
Nimodipine—Dyspnoea—Progesterone—uterine cancer	0.000713	0.00545	CcSEcCtD
Nimodipine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00071	0.00543	CcSEcCtD
Nimodipine—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000709	0.00542	CcSEcCtD
Nimodipine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000707	0.0054	CcSEcCtD
Nimodipine—Sweating increased—Etoposide—uterine cancer	0.0007	0.00535	CcSEcCtD
Nimodipine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.0007	0.00535	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Progesterone—uterine cancer	0.00069	0.00527	CcSEcCtD
Nimodipine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000677	0.00517	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00066	0.00504	CcSEcCtD
Nimodipine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000646	0.00493	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Epirubicin—uterine cancer	0.000642	0.00491	CcSEcCtD
Nimodipine—Anaemia—Dactinomycin—uterine cancer	0.00064	0.00489	CcSEcCtD
Nimodipine—CYP3A4—renal system—uterine cancer	0.000631	0.00679	CbGeAlD
Nimodipine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000625	0.00478	CcSEcCtD
Nimodipine—Jaundice—Etoposide—uterine cancer	0.000625	0.00478	CcSEcCtD
Nimodipine—CYP3A5—female gonad—uterine cancer	0.000613	0.0066	CbGeAlD
Nimodipine—Fluid retention—Epirubicin—uterine cancer	0.00061	0.00466	CcSEcCtD
Nimodipine—CYP3A5—vagina—uterine cancer	0.000609	0.00656	CbGeAlD
Nimodipine—Hepatobiliary disease—Etoposide—uterine cancer	0.000606	0.00463	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Doxorubicin—uterine cancer	0.000594	0.00454	CcSEcCtD
Nimodipine—Myalgia—Dactinomycin—uterine cancer	0.000589	0.0045	CcSEcCtD
Nimodipine—Hypersensitivity—Progesterone—uterine cancer	0.000589	0.0045	CcSEcCtD
Nimodipine—Pruritus—Progesterone—uterine cancer	0.000566	0.00432	CcSEcCtD
Nimodipine—Oedema—Dactinomycin—uterine cancer	0.000565	0.00432	CcSEcCtD
Nimodipine—Fluid retention—Doxorubicin—uterine cancer	0.000564	0.00431	CcSEcCtD
Nimodipine—Thrombocytopenia—Dactinomycin—uterine cancer	0.000553	0.00423	CcSEcCtD
Nimodipine—Diarrhoea—Progesterone—uterine cancer	0.000547	0.00418	CcSEcCtD
Nimodipine—Phlebitis—Epirubicin—uterine cancer	0.000541	0.00414	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.000536	0.0041	CcSEcCtD
Nimodipine—Flushing—Etoposide—uterine cancer	0.000534	0.00408	CcSEcCtD
Nimodipine—Cardiac disorder—Etoposide—uterine cancer	0.000534	0.00408	CcSEcCtD
Nimodipine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000534	0.00408	CcSEcCtD
Nimodipine—Dizziness—Progesterone—uterine cancer	0.000529	0.00404	CcSEcCtD
Nimodipine—Angiopathy—Etoposide—uterine cancer	0.000522	0.00399	CcSEcCtD
Nimodipine—Immune system disorder—Etoposide—uterine cancer	0.00052	0.00397	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000515	0.00393	CcSEcCtD
Nimodipine—Cardiac failure congestive—Epirubicin—uterine cancer	0.000514	0.00393	CcSEcCtD
Nimodipine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000512	0.00392	CcSEcCtD
Nimodipine—Vomiting—Progesterone—uterine cancer	0.000508	0.00388	CcSEcCtD
Nimodipine—CYP3A4—female reproductive system—uterine cancer	0.000506	0.00544	CbGeAlD
Nimodipine—Rash—Progesterone—uterine cancer	0.000504	0.00385	CcSEcCtD
Nimodipine—Dermatitis—Progesterone—uterine cancer	0.000504	0.00385	CcSEcCtD
Nimodipine—Phlebitis—Doxorubicin—uterine cancer	0.000501	0.00383	CcSEcCtD
Nimodipine—Headache—Progesterone—uterine cancer	0.000501	0.00383	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.000496	0.00379	CcSEcCtD
Nimodipine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000496	0.00379	CcSEcCtD
Nimodipine—Muscle spasms—Etoposide—uterine cancer	0.000482	0.00368	CcSEcCtD
Nimodipine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000479	0.00366	CcSEcCtD
Nimodipine—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000476	0.00364	CcSEcCtD
Nimodipine—Nausea—Progesterone—uterine cancer	0.000475	0.00363	CcSEcCtD
Nimodipine—Hyponatraemia—Epirubicin—uterine cancer	0.000468	0.00358	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000466	0.00356	CcSEcCtD
Nimodipine—Anaemia—Etoposide—uterine cancer	0.000463	0.00354	CcSEcCtD
Nimodipine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000461	0.00352	CcSEcCtD
Nimodipine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000457	0.00349	CcSEcCtD
Nimodipine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000456	0.00349	CcSEcCtD
Nimodipine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000454	0.00347	CcSEcCtD
Nimodipine—Hyponatraemia—Doxorubicin—uterine cancer	0.000433	0.00331	CcSEcCtD
Nimodipine—Hypertension—Etoposide—uterine cancer	0.000433	0.00331	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000431	0.0033	CcSEcCtD
Nimodipine—Liver function test abnormal—Epirubicin—uterine cancer	0.000431	0.00329	CcSEcCtD
Nimodipine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00043	0.00329	CcSEcCtD
Nimodipine—Hypersensitivity—Dactinomycin—uterine cancer	0.000416	0.00318	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000411	0.00314	CcSEcCtD
Nimodipine—Thrombocytopenia—Etoposide—uterine cancer	0.0004	0.00306	CcSEcCtD
Nimodipine—Tachycardia—Etoposide—uterine cancer	0.000399	0.00305	CcSEcCtD
Nimodipine—Liver function test abnormal—Doxorubicin—uterine cancer	0.000398	0.00304	CcSEcCtD
Nimodipine—Hyperhidrosis—Etoposide—uterine cancer	0.000395	0.00302	CcSEcCtD
Nimodipine—Diarrhoea—Dactinomycin—uterine cancer	0.000387	0.00295	CcSEcCtD
Nimodipine—Hypotension—Etoposide—uterine cancer	0.000382	0.00292	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000381	0.00291	CcSEcCtD
Nimodipine—Dyspnoea—Etoposide—uterine cancer	0.000365	0.00279	CcSEcCtD
Nimodipine—Vomiting—Dactinomycin—uterine cancer	0.000359	0.00274	CcSEcCtD
Nimodipine—Rash—Dactinomycin—uterine cancer	0.000356	0.00272	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000353	0.0027	CcSEcCtD
Nimodipine—Jaundice—Epirubicin—uterine cancer	0.00035	0.00268	CcSEcCtD
Nimodipine—Hepatobiliary disease—Epirubicin—uterine cancer	0.00034	0.0026	CcSEcCtD
Nimodipine—Nausea—Dactinomycin—uterine cancer	0.000336	0.00256	CcSEcCtD
Nimodipine—Bradycardia—Epirubicin—uterine cancer	0.000328	0.00251	CcSEcCtD
Nimodipine—Jaundice—Doxorubicin—uterine cancer	0.000324	0.00248	CcSEcCtD
Nimodipine—Hepatitis—Epirubicin—uterine cancer	0.000323	0.00247	CcSEcCtD
Nimodipine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000314	0.0024	CcSEcCtD
Nimodipine—Bradycardia—Doxorubicin—uterine cancer	0.000304	0.00232	CcSEcCtD
Nimodipine—Hypersensitivity—Etoposide—uterine cancer	0.000301	0.0023	CcSEcCtD
Nimodipine—Flushing—Epirubicin—uterine cancer	0.000299	0.00229	CcSEcCtD
Nimodipine—Cardiac disorder—Epirubicin—uterine cancer	0.000299	0.00229	CcSEcCtD
Nimodipine—Hepatitis—Doxorubicin—uterine cancer	0.000299	0.00228	CcSEcCtD
Nimodipine—Angiopathy—Epirubicin—uterine cancer	0.000293	0.00224	CcSEcCtD
Nimodipine—Immune system disorder—Epirubicin—uterine cancer	0.000291	0.00223	CcSEcCtD
Nimodipine—Pruritus—Etoposide—uterine cancer	0.000289	0.00221	CcSEcCtD
Nimodipine—Diarrhoea—Etoposide—uterine cancer	0.00028	0.00214	CcSEcCtD
Nimodipine—Cardiac disorder—Doxorubicin—uterine cancer	0.000277	0.00212	CcSEcCtD
Nimodipine—Flushing—Doxorubicin—uterine cancer	0.000277	0.00212	CcSEcCtD
Nimodipine—Angiopathy—Doxorubicin—uterine cancer	0.000271	0.00207	CcSEcCtD
Nimodipine—Dizziness—Etoposide—uterine cancer	0.00027	0.00207	CcSEcCtD
Nimodipine—Muscle spasms—Epirubicin—uterine cancer	0.00027	0.00206	CcSEcCtD
Nimodipine—Immune system disorder—Doxorubicin—uterine cancer	0.00027	0.00206	CcSEcCtD
Nimodipine—Vomiting—Etoposide—uterine cancer	0.00026	0.00199	CcSEcCtD
Nimodipine—Anaemia—Epirubicin—uterine cancer	0.00026	0.00198	CcSEcCtD
Nimodipine—Rash—Etoposide—uterine cancer	0.000258	0.00197	CcSEcCtD
Nimodipine—Dermatitis—Etoposide—uterine cancer	0.000258	0.00197	CcSEcCtD
Nimodipine—Headache—Etoposide—uterine cancer	0.000256	0.00196	CcSEcCtD
Nimodipine—Muscle spasms—Doxorubicin—uterine cancer	0.00025	0.00191	CcSEcCtD
Nimodipine—Palpitations—Epirubicin—uterine cancer	0.000248	0.0019	CcSEcCtD
Nimodipine—Nausea—Etoposide—uterine cancer	0.000243	0.00186	CcSEcCtD
Nimodipine—Hypertension—Epirubicin—uterine cancer	0.000242	0.00185	CcSEcCtD
Nimodipine—Anaemia—Doxorubicin—uterine cancer	0.00024	0.00184	CcSEcCtD
Nimodipine—Myalgia—Epirubicin—uterine cancer	0.000239	0.00183	CcSEcCtD
Nimodipine—Palpitations—Doxorubicin—uterine cancer	0.00023	0.00175	CcSEcCtD
Nimodipine—Oedema—Epirubicin—uterine cancer	0.000229	0.00175	CcSEcCtD
Nimodipine—Nervous system disorder—Epirubicin—uterine cancer	0.000225	0.00172	CcSEcCtD
Nimodipine—Thrombocytopenia—Epirubicin—uterine cancer	0.000224	0.00171	CcSEcCtD
Nimodipine—Hypertension—Doxorubicin—uterine cancer	0.000224	0.00171	CcSEcCtD
Nimodipine—Tachycardia—Epirubicin—uterine cancer	0.000224	0.00171	CcSEcCtD
Nimodipine—Hyperhidrosis—Epirubicin—uterine cancer	0.000222	0.00169	CcSEcCtD
Nimodipine—Myalgia—Doxorubicin—uterine cancer	0.000221	0.00169	CcSEcCtD
Nimodipine—Hypotension—Epirubicin—uterine cancer	0.000214	0.00164	CcSEcCtD
Nimodipine—Oedema—Doxorubicin—uterine cancer	0.000212	0.00162	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000209	0.0016	CcSEcCtD
Nimodipine—Nervous system disorder—Doxorubicin—uterine cancer	0.000208	0.00159	CcSEcCtD
Nimodipine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000208	0.00159	CcSEcCtD
Nimodipine—Tachycardia—Doxorubicin—uterine cancer	0.000207	0.00158	CcSEcCtD
Nimodipine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000205	0.00157	CcSEcCtD
Nimodipine—Dyspnoea—Epirubicin—uterine cancer	0.000204	0.00156	CcSEcCtD
Nimodipine—Hypotension—Doxorubicin—uterine cancer	0.000198	0.00151	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000198	0.00151	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000193	0.00148	CcSEcCtD
Nimodipine—Dyspnoea—Doxorubicin—uterine cancer	0.000189	0.00144	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000183	0.0014	CcSEcCtD
Nimodipine—Hypersensitivity—Epirubicin—uterine cancer	0.000169	0.00129	CcSEcCtD
Nimodipine—Pruritus—Epirubicin—uterine cancer	0.000162	0.00124	CcSEcCtD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—HRAS—uterine cancer	0.000162	0.00188	CbGpPWpGaD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—KRAS—uterine cancer	0.000158	0.00184	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—SMAD3—uterine cancer	0.000158	0.00184	CbGpPWpGaD
Nimodipine—Diarrhoea—Epirubicin—uterine cancer	0.000157	0.0012	CcSEcCtD
Nimodipine—Hypersensitivity—Doxorubicin—uterine cancer	0.000156	0.00119	CcSEcCtD
Nimodipine—NR3C2—Generic Transcription Pathway—SMAD3—uterine cancer	0.000155	0.00181	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—HRAS—uterine cancer	0.000153	0.00178	CbGpPWpGaD
Nimodipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000153	0.00178	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—AKT1—uterine cancer	0.000152	0.00177	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—SRD5A2—uterine cancer	0.000152	0.00177	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—NDUFB11—uterine cancer	0.000152	0.00177	CbGpPWpGaD
Nimodipine—Dizziness—Epirubicin—uterine cancer	0.000152	0.00116	CcSEcCtD
Nimodipine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000151	0.00175	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—GPX3—uterine cancer	0.00015	0.00175	CbGpPWpGaD
Nimodipine—Pruritus—Doxorubicin—uterine cancer	0.00015	0.00115	CcSEcCtD
Nimodipine—Vomiting—Epirubicin—uterine cancer	0.000146	0.00111	CcSEcCtD
Nimodipine—Diarrhoea—Doxorubicin—uterine cancer	0.000145	0.00111	CcSEcCtD
Nimodipine—Rash—Epirubicin—uterine cancer	0.000145	0.0011	CcSEcCtD
Nimodipine—Dermatitis—Epirubicin—uterine cancer	0.000144	0.0011	CcSEcCtD
Nimodipine—CACNA1D—Metabolism—NDUFB11—uterine cancer	0.000144	0.00167	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—SRD5A2—uterine cancer	0.000144	0.00167	CbGpPWpGaD
Nimodipine—Headache—Epirubicin—uterine cancer	0.000144	0.0011	CcSEcCtD
Nimodipine—AHR—Circadian rythm related genes—TP53—uterine cancer	0.000143	0.00167	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—TP53—uterine cancer	0.000142	0.00166	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—CYP11A1—uterine cancer	0.000141	0.00165	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—POLD1—uterine cancer	0.000141	0.00164	CbGpPWpGaD
Nimodipine—Dizziness—Doxorubicin—uterine cancer	0.00014	0.00107	CcSEcCtD
Nimodipine—CACNB4—Transmission across Chemical Synapses—HRAS—uterine cancer	0.00014	0.00163	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—CYP11A1—uterine cancer	0.000139	0.00162	CbGpPWpGaD
Nimodipine—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000139	0.00162	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—ERBB2—uterine cancer	0.000137	0.00159	CbGpPWpGaD
Nimodipine—Nausea—Epirubicin—uterine cancer	0.000136	0.00104	CcSEcCtD
Nimodipine—Vomiting—Doxorubicin—uterine cancer	0.000135	0.00103	CcSEcCtD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—HRAS—uterine cancer	0.000135	0.00157	CbGpPWpGaD
Nimodipine—Rash—Doxorubicin—uterine cancer	0.000134	0.00102	CcSEcCtD
Nimodipine—Dermatitis—Doxorubicin—uterine cancer	0.000134	0.00102	CcSEcCtD
Nimodipine—CACNB3—Developmental Biology—MET—uterine cancer	0.000133	0.00155	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—MET—uterine cancer	0.000133	0.00155	CbGpPWpGaD
Nimodipine—Headache—Doxorubicin—uterine cancer	0.000133	0.00102	CcSEcCtD
Nimodipine—CACNB1—Axon guidance—ERBB2—uterine cancer	0.000133	0.00155	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—AKR1C1—uterine cancer	0.000132	0.00153	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—AKR1C3—uterine cancer	0.000132	0.00153	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—VEGFA—uterine cancer	0.000132	0.00153	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—NRAS—uterine cancer	0.00013	0.00151	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—MET—uterine cancer	0.00013	0.00151	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—ESR1—uterine cancer	0.000127	0.00147	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NDUFB11—uterine cancer	0.000126	0.00147	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—SRD5A2—uterine cancer	0.000126	0.00147	CbGpPWpGaD
Nimodipine—Nausea—Doxorubicin—uterine cancer	0.000126	0.000963	CcSEcCtD
Nimodipine—CACNA1C—Alzheimers Disease—TP53—uterine cancer	0.000125	0.00145	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000124	0.00144	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—ERBB2—uterine cancer	0.000122	0.00142	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—RRM2—uterine cancer	0.000117	0.00137	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000117	0.00136	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—SMAD3—uterine cancer	0.000116	0.00135	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—PGR—uterine cancer	0.000114	0.00133	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—MET—uterine cancer	0.000114	0.00133	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—DCN—uterine cancer	0.000114	0.00133	CbGpPWpGaD
Nimodipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000112	0.00131	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—KRAS—uterine cancer	0.000112	0.0013	CbGpPWpGaD
Nimodipine—CACNB3—Transmission across Chemical Synapses—HRAS—uterine cancer	0.000112	0.0013	CbGpPWpGaD
Nimodipine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000111	0.00129	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—STAR—uterine cancer	0.00011	0.00128	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AKR1B1—uterine cancer	0.00011	0.00128	CbGpPWpGaD
Nimodipine—CACNB1—Transmission across Chemical Synapses—HRAS—uterine cancer	0.000109	0.00127	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—EZH2—uterine cancer	0.000108	0.00126	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	0.000108	0.00126	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MET—uterine cancer	0.000108	0.00126	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CYP11A1—uterine cancer	0.000107	0.00125	CbGpPWpGaD
Nimodipine—CACNB4—Neuronal System—HRAS—uterine cancer	0.000107	0.00125	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—CTNNB1—uterine cancer	0.000107	0.00124	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—VEGFA—uterine cancer	0.000105	0.00122	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—CYP19A1—uterine cancer	0.000104	0.00121	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AKR1B1—uterine cancer	0.000104	0.00121	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—STAR—uterine cancer	0.000104	0.00121	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—NRAS—uterine cancer	0.000104	0.00121	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—CYP19A1—uterine cancer	0.000103	0.00119	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—VEGFA—uterine cancer	0.000102	0.00119	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—AKR1C3—uterine cancer	0.000101	0.00118	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—NRAS—uterine cancer	0.000101	0.00118	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—ESR2—uterine cancer	0.000101	0.00117	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—SMAD3—uterine cancer	9.94e-05	0.00116	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—EP300—uterine cancer	9.91e-05	0.00115	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—ERBB2—uterine cancer	9.74e-05	0.00113	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—ERBB2—uterine cancer	9.73e-05	0.00113	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—HRAS—uterine cancer	9.51e-05	0.00111	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MET—uterine cancer	9.5e-05	0.00111	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MET—uterine cancer	9.5e-05	0.00111	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—ERBB2—uterine cancer	9.48e-05	0.0011	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—SMAD3—uterine cancer	9.41e-05	0.0011	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—VEGFA—uterine cancer	9.39e-05	0.00109	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—NRAS—uterine cancer	9.27e-05	0.00108	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AKR1B1—uterine cancer	9.13e-05	0.00106	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—STAR—uterine cancer	9.13e-05	0.00106	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	9.1e-05	0.00106	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—KRAS—uterine cancer	8.94e-05	0.00104	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—KRAS—uterine cancer	8.7e-05	0.00101	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—POLD1—uterine cancer	8.61e-05	0.001	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—HRAS—uterine cancer	8.56e-05	0.000997	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—CTNNB1—uterine cancer	8.52e-05	0.000993	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—ERBB2—uterine cancer	8.34e-05	0.000971	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—HRAS—uterine cancer	8.33e-05	0.00097	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—CTNNB1—uterine cancer	8.29e-05	0.000965	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—SMAD3—uterine cancer	8.27e-05	0.000963	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—CDKN2B—uterine cancer	8.18e-05	0.000953	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—POLD1—uterine cancer	8.15e-05	0.000949	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MET—uterine cancer	8.14e-05	0.000948	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AKR1C1—uterine cancer	8.05e-05	0.000937	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—KRAS—uterine cancer	7.98e-05	0.000929	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	7.95e-05	0.000926	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—EP300—uterine cancer	7.92e-05	0.000923	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—STK11—uterine cancer	7.9e-05	0.00092	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CYP19A1—uterine cancer	7.9e-05	0.00092	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—ERBB2—uterine cancer	7.9e-05	0.00092	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MET—uterine cancer	7.71e-05	0.000898	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—EP300—uterine cancer	7.71e-05	0.000897	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AKR1C1—uterine cancer	7.62e-05	0.000888	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—HRAS—uterine cancer	7.6e-05	0.000885	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—VEGFA—uterine cancer	7.5e-05	0.000874	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—VEGFA—uterine cancer	7.49e-05	0.000872	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—SMAD3—uterine cancer	7.47e-05	0.00087	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—NRAS—uterine cancer	7.41e-05	0.000863	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—NRAS—uterine cancer	7.4e-05	0.000862	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—HRAS—uterine cancer	7.39e-05	0.000861	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—VEGFA—uterine cancer	7.3e-05	0.00085	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—NRAS—uterine cancer	7.21e-05	0.00084	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—RRM2—uterine cancer	7.18e-05	0.000836	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—POLD1—uterine cancer	7.16e-05	0.000834	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	6.98e-05	0.000813	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—DCN—uterine cancer	6.97e-05	0.000811	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—ERBB2—uterine cancer	6.94e-05	0.000808	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—ERBB2—uterine cancer	6.94e-05	0.000808	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—HRAS—uterine cancer	6.83e-05	0.000795	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—RRM2—uterine cancer	6.8e-05	0.000791	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—HRAS—uterine cancer	6.78e-05	0.00079	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MET—uterine cancer	6.78e-05	0.000789	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AKR1C1—uterine cancer	6.7e-05	0.00078	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—DCN—uterine cancer	6.6e-05	0.000768	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	6.57e-05	0.000765	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP11A1—uterine cancer	6.56e-05	0.000764	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	6.48e-05	0.000755	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—VEGFA—uterine cancer	6.42e-05	0.000748	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—KRAS—uterine cancer	6.38e-05	0.000743	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—KRAS—uterine cancer	6.37e-05	0.000742	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—NRAS—uterine cancer	6.35e-05	0.000739	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP11A1—uterine cancer	6.22e-05	0.000724	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—KRAS—uterine cancer	6.21e-05	0.000723	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AKR1C3—uterine cancer	6.2e-05	0.000722	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	6.12e-05	0.000713	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—ESR1—uterine cancer	6.1e-05	0.00071	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—VEGFA—uterine cancer	6.08e-05	0.000708	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—CTNNB1—uterine cancer	6.07e-05	0.000707	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—NRAS—uterine cancer	6.01e-05	0.0007	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—AKT1—uterine cancer	5.99e-05	0.000697	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—RRM2—uterine cancer	5.97e-05	0.000695	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—ERBB2—uterine cancer	5.95e-05	0.000693	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—MTHFR—uterine cancer	5.94e-05	0.000692	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AKR1C3—uterine cancer	5.87e-05	0.000683	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—DCN—uterine cancer	5.8e-05	0.000675	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—EP300—uterine cancer	5.65e-05	0.000657	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—ERBB2—uterine cancer	5.64e-05	0.000656	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NDUFB11—uterine cancer	5.59e-05	0.000651	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SRD5A2—uterine cancer	5.59e-05	0.000651	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—KRAS—uterine cancer	5.46e-05	0.000636	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP11A1—uterine cancer	5.46e-05	0.000636	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—HRAS—uterine cancer	5.42e-05	0.000631	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—HRAS—uterine cancer	5.41e-05	0.00063	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—VEGFA—uterine cancer	5.35e-05	0.000623	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—VEGFA—uterine cancer	5.35e-05	0.000622	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—NRAS—uterine cancer	5.28e-05	0.000615	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—NRAS—uterine cancer	5.28e-05	0.000615	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—HRAS—uterine cancer	5.28e-05	0.000614	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—HRAS—uterine cancer	5.23e-05	0.000609	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—CTNNB1—uterine cancer	5.21e-05	0.000606	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—KRAS—uterine cancer	5.17e-05	0.000602	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AKR1C3—uterine cancer	5.16e-05	0.0006	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—ERBB2—uterine cancer	4.95e-05	0.000577	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—CTNNB1—uterine cancer	4.93e-05	0.000574	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—EP300—uterine cancer	4.84e-05	0.000564	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	4.84e-05	0.000563	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP19A1—uterine cancer	4.83e-05	0.000562	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—STK11—uterine cancer	4.83e-05	0.000562	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—AKT1—uterine cancer	4.79e-05	0.000557	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	4.77e-05	0.000555	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—AKT1—uterine cancer	4.66e-05	0.000542	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—HRAS—uterine cancer	4.64e-05	0.00054	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—VEGFA—uterine cancer	4.58e-05	0.000534	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—EP300—uterine cancer	4.58e-05	0.000534	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—STK11—uterine cancer	4.57e-05	0.000532	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP19A1—uterine cancer	4.57e-05	0.000532	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—KRAS—uterine cancer	4.55e-05	0.000529	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—KRAS—uterine cancer	4.54e-05	0.000529	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—NRAS—uterine cancer	4.53e-05	0.000527	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—HRAS—uterine cancer	4.4e-05	0.000512	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—VEGFA—uterine cancer	4.34e-05	0.000505	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—CTNNB1—uterine cancer	4.33e-05	0.000504	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—NRAS—uterine cancer	4.29e-05	0.000499	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—STAR—uterine cancer	4.04e-05	0.00047	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKR1B1—uterine cancer	4.04e-05	0.00047	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EP300—uterine cancer	4.03e-05	0.000469	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—STK11—uterine cancer	4.02e-05	0.000468	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP19A1—uterine cancer	4.02e-05	0.000468	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—KRAS—uterine cancer	3.9e-05	0.000454	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—HRAS—uterine cancer	3.86e-05	0.00045	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—HRAS—uterine cancer	3.86e-05	0.00045	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—VEGFA—uterine cancer	3.81e-05	0.000444	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—NRAS—uterine cancer	3.77e-05	0.000439	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—KRAS—uterine cancer	3.69e-05	0.00043	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—MTHFR—uterine cancer	3.63e-05	0.000422	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—MTHFR—uterine cancer	3.44e-05	0.0004	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—AKT1—uterine cancer	3.41e-05	0.000397	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—HRAS—uterine cancer	3.31e-05	0.000386	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTEN—uterine cancer	3.3e-05	0.000385	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—KRAS—uterine cancer	3.24e-05	0.000378	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—POLD1—uterine cancer	3.17e-05	0.000369	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—EP300—uterine cancer	3.15e-05	0.000367	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—HRAS—uterine cancer	3.14e-05	0.000365	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—MTHFR—uterine cancer	3.02e-05	0.000352	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKR1C1—uterine cancer	2.97e-05	0.000345	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—AKT1—uterine cancer	2.93e-05	0.000341	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—AKT1—uterine cancer	2.77e-05	0.000323	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—HRAS—uterine cancer	2.76e-05	0.000321	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—RRM2—uterine cancer	2.64e-05	0.000308	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SRD5A2—uterine cancer	2.6e-05	0.000302	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NDUFB11—uterine cancer	2.6e-05	0.000302	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—DCN—uterine cancer	2.57e-05	0.000299	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—AKT1—uterine cancer	2.43e-05	0.000283	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP11A1—uterine cancer	2.42e-05	0.000281	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CA—uterine cancer	2.33e-05	0.000271	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKR1C3—uterine cancer	2.28e-05	0.000266	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—AKT1—uterine cancer	2.2e-05	0.000256	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTEN—uterine cancer	2.02e-05	0.000235	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—EP300—uterine cancer	1.93e-05	0.000224	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTEN—uterine cancer	1.91e-05	0.000223	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—AKT1—uterine cancer	1.9e-05	0.000222	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.88e-05	0.000219	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—STAR—uterine cancer	1.88e-05	0.000219	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—EP300—uterine cancer	1.82e-05	0.000212	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP19A1—uterine cancer	1.78e-05	0.000207	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—STK11—uterine cancer	1.78e-05	0.000207	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTEN—uterine cancer	1.68e-05	0.000196	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—EP300—uterine cancer	1.6e-05	0.000187	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—POLD1—uterine cancer	1.47e-05	0.000172	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CA—uterine cancer	1.42e-05	0.000166	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.38e-05	0.000161	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CA—uterine cancer	1.35e-05	0.000157	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—MTHFR—uterine cancer	1.34e-05	0.000156	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—RRM2—uterine cancer	1.23e-05	0.000143	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—DCN—uterine cancer	1.19e-05	0.000139	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CA—uterine cancer	1.18e-05	0.000138	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AKT1—uterine cancer	1.16e-05	0.000135	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.12e-05	0.000131	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AKT1—uterine cancer	1.1e-05	0.000128	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.06e-05	0.000124	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AKT1—uterine cancer	9.68e-06	0.000113	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP19A1—uterine cancer	8.27e-06	9.63e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—STK11—uterine cancer	8.27e-06	9.63e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTEN—uterine cancer	7.44e-06	8.66e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—EP300—uterine cancer	7.09e-06	8.26e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MTHFR—uterine cancer	6.21e-06	7.23e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CA—uterine cancer	5.25e-06	6.11e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKT1—uterine cancer	4.28e-06	4.99e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTEN—uterine cancer	3.46e-06	4.02e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—EP300—uterine cancer	3.3e-06	3.84e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.44e-06	2.84e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKT1—uterine cancer	1.99e-06	2.32e-05	CbGpPWpGaD
